Cara Therapeutics NASDAQCARA investor five-year losses grow to 78 percent as the stock sheds US24m this past week

CARA Stock  USD 0.27  0.02  6.90%   
About 67% of Cara Therapeutic's investor base is looking to short. The analysis of overall sentiment of trading Cara Therapeutic stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cara Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Cara Therapeutic stock news signals to limit their universe of possible portfolio assets.
  
Were definitely into long term investing, but some companies are simply bad investments over any time frame. We dont...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Cara Therapeutic Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cara Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cara Therapeutic Fundamental Analysis

We analyze Cara Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cara Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cara Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Cara Therapeutic is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Cara Therapeutic Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cara Therapeutic stock to make a market-neutral strategy. Peer analysis of Cara Therapeutic could also be used in its relative valuation, which is a method of valuing Cara Therapeutic by comparing valuation metrics with similar companies.

Peers

Cara Therapeutic Related Equities

VCNXVaccinex   5.28   
0%
100.0%
DNTHDianthus Therapeutics   2.27   
0%
42.0%
VCELVericel Corp   2.13   
0%
40.0%
VCYTVeracyte   0.51   
0%
9.0%
DOMHDominari Holdings   1.19   
22.0%
0%
DNLIDenali Therapeutics   1.88   
35.0%
0%
VALNValneva SE   2.09   
39.0%
0%
DMACDiaMedica Therapeutics   3.19   
60.0%
0%
VANIVivani Medical   3.76   
71.0%
0%
EQEquillium   4.11   
77.0%
0%

Complementary Tools for Cara Stock analysis

When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios